Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Purine derivatives as CB2 receptor agonists

Purine derivatives as CB2 receptor agonists

US Patent 9505762 · Granted Nov 29, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nitrogen-containing heterocyclic compound having NRF2 activation effect2025
Heterocyclic compounds as monoacylglycerol lipase inhibitors2025
Spirocyclic compounds2025
Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabino2024
Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 22024
Radiolabeled cannabinoid receptor 2 ligand2024
Heterocyclic compounds2024
Heterocyclic compounds2023
Heterocyclic compounds as monoacylglycerol lipase inhibitors2023
Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists2023
Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors2023
Spirocyclic compounds2023